Peri-operative care in patients treated for testicular cancer

Seminars in Surgical Oncology

Volumn 17, Issue 4, 1999, Pages 282-288

  Donat, S Machele ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adult respiratory distress syndrome; Bleomycin adverse effects toxicity; Chyloperitoneum; Cisplatin adverse effects toxicity; Combined antineoplastic agents; Combined modality therapy; Fluid therapy; General anesthesia; Germ cell and embryonal neoplasms; Kidney diseases; Liver diseases chemically induced; Lung diseases chemically induced; Lymph node excision; Neoplasm metastasis; Oxygen; Postoperative complications; Preoperative care; Prognosis; Pulmonary fibrosis; Radiotherapy; Seminoma; Testicular neoplasms; Vascular neoplasms; Vinblastine adverse effects toxicity

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; HUMAN; LUNG TOXICITY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TESTIS CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; GERMINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROPERITONEAL SPACE; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0032763864     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199912)17:4<282::AID-SSU10>3.0.CO;2-V     Document Type: Review

References (32)

1. Foster RS, Donohue JP: Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy? [Review]. Urol Clin North Am 1998;25:479-484.
2. Toner GC, Panicek DM, Heelan RT, et al: Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990;8:1683-1694.
3. Herr HW, Sheinfeld JS, Pue HS, et al: Surgery for a post-chemotherapy residual mass in seminoma [Review]. J Urol 1997;157: 860-862.
4. Moul JW: Early complications and toxicities of testicular cancer therapy. Probl Urol 1994;8:141-153.
5. Brenner PC, Herr HW, Morse MJ, et al: Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumor of the testis. J Clin Oncol 1996;14:1765-1769.
6. Tognini PG, Foster RS, McGraw P, et al: Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology [published erratum appears in J Urol 1998; 160:1444]. J Urol 1998;159:1833-1835.
7. Christmas TJ, Doherty AP, Rustin GJ, et al: Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches. Br J Urol 1998;81: 301-308.
8. Rukstalis DB, Chodak GW: Laparoscopic retroperitoneal lymph node dissection in a patient with stage I testicular carcinoma. J Urol 1992;148:1907-1910.
9. Winfield HN: Laparoscopic retroperitoneal lymphadenectomy for cancer of the testis [Review]. Urol Clin North Am 1998;25:469-478.
10. Gill IS, McDougall EM, Clayman RV: Laparoscopic oncology. In Oesterling JE, Richie JP (eds): "Urologie oncology." Philadelphia: WB Saunders; 1997. p. 697-725.
11. Spitz A, Wilson TG, Kawachi MH, et al: Vena caval resection for bulky metastatic germ cell tumors: an 18-year experience. J Urol 1997;158:1813-1818.
12. Pisters LL, Coral DA, Donat SM, et al: Magnetic resonance imaging and magnetic angiography prior to post-chemotherapy retroperitoneal lymphadenectomy [Abstract]. J Urol 1998;159:50A. #182.
13. Beck SD, Foster RS, Bihrle R, et al: Long term morbidity and survival in patients undergoing vena cava resection for metastatic germ cell tumors [Abstract]. J Urol 1999;161:158A. #607.
14. Goldiner PL, Schweizer O: The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 1979;6:121-124.
15. Ablan CJ, Littooy FN, Freeark RJ: Postoperative chylous ascites: diagnosis and treatment [Review]. Arch Surg 1990;125:270-273.
16. Ferrigni RG, Novicki DE: Chylous ascites complicating genitourinary oncological surgery. J Urol 1985;134:774-776.
17. rd, McIntyre KE Jr, Schilling JD, et al: Management of chyloperitoneum after abdominal aortic surgery. Am J Surg 1993;166:194-199.
18. Marts BC, Naunheim KS, Fiore AC, Pennington DG: Conservative versus surgical management of chylothorax. Am J Surg 1992;164: 532-535.
19. Boyer MJ, Raghavan D: Long-term morbidity of testicular cancer treatment. Probl Urol 1994;8:154-166.
20. Grossfeld GD, Small EJ: Long-term side effects of treatment for testis cancer. Urol Clin North Am 1998;25:503-515.
21. Comis RL: Bleomycin pulmonary toxidty. In Carter SK, Crooke ST, Umezawa H (eds): "Bleomycin: current status and new developments." New York: Academic Press; 1978. p. 279-291.
22. Van Barneveld PW, van der Mark TW, Sleijfer DT, et al: Predictive factors for bleomycin-induced pneumonitis. Am Rev Resp Dis 1984;130:1078-1081.
23. De Lena M, Guzzon A, Monfardini, et al: Clinical, radiologic, and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin. Cancer Chemother Rep 1972;56:343-356.
24. Blum RH, Carter SK, Agre K: A clinical review of bleomycin - a new antineoplastic agent. Cancer 1973;31:903-914.
25. Jules-Elysee K, White DA: Bleomycin-induced pulmonary toxicity [Review]. Clin Chest Med 1990;11:1-20.
26. Donat SM, Levy DA: Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary? J Urol 1998;160:1347-1352.
27. Dorje P, Tremper KK: Anesthesia for major cancer surgery. In Oesterling JE, Richie JP (eds): "Urologic oncology." Philadelphia: WB Saunders; 1997. p. 748-767.
28. Waid-Jones MI, Coursin DB: Perioperative considerations for patients treated with bleomycin [Review]. Chest 1991;99:993-999.
29. Comis RL: Bleomycin pulmonary toxicity: current status and future directions [Review]. Semin Oncol 1992;19(2 Suppl 5):64-70.
30. Sleijfer S, van der Mark TW, Schraffordt Koops H, et al: Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect. Br J Urol 1995;71:120-123.
31. Baniel J, Foster RS, Rowland RG, et al: Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 1995; 153(3 Pt 1):976-980.
32. LaMantia KR, Click JH, Marshall BE: Supplemental oxygen does not cause respiratory failure in bleomycin-treated surgical patients. Anesthesiology 1984;60:65-67.